MedPath

A randomized controlled trial of a senior centre group program for increasing social support and preventing depression in elderly people living in Norway

Conditions
ATE LIFE DEPRESSION
F32.1
F32.2
Moderate depressive episode
Severe depressive episode without psychotic symptoms
Registration Number
DRKS00003120
Lead Sponsor
orwegian Institute of Public Health, Division of Mental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
138
Inclusion Criteria

Psychological distress, self-reported, not a regular user of the senior -centre, Norwegian speaking, able to communicate in an understandable way, wanted to be a partcipant

Exclusion Criteria

regular users of senior centre, not speaking Norwegian, too mentally or physically ill.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One outcome parameter was social support, as measured by scores on the Oslo-3 Social support scale (OSS-3). OSS-3 is based on three questions, with scores on each item and a sum score.<br>Oslo1: How many people are you so close o that you can count on them if you have great personal problems?<br>Oslo2: How much interest and concern do people show in what you do?<br>Oslo3: How easy is it to get practical help from neighbors if you should need it.<br><br>Another outcome parameter was depression/psychological distress as measured on the Beck Depression Inventory (BDI).<br><br>The participants n=92 were measured at baseline and after six months and again after 12 months after the intervention started.
Secondary Outcome Measures
NameTimeMethod
Secondary outcome parametres was:<br>- life satisfaction, as measured by scores on a question about quality of life<br>- self-reported health, as measured by scores on a question of health<br>- after 12 months the intervention group was also asked how musch the weekly program meant to them. They were also asked if they had got new friends or met the participants in private settings.<br><br>All these measurements (both primary and secondary) were conducted in an identical manner in face-tofaceinterviews first at baseline and then at 12 months follow-up when intervention had come to an end.
© Copyright 2025. All Rights Reserved by MedPath